Back to Archived Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   HTML views PDF downloads Totals
16,848 Dovepress* 11,799+ 4,740 16,539
PubMed Central* 5,049 1,451 6,500
Totals 16,848 6,191 23,039
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar